USPTO serial 97333755
ADM
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- LE, KIEU-NHI NGOC
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ADM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary E. Innis
Mary E. Innis INNIS LAW GROUP LLC321 N. CLARK ST.SUITE 2465CHICAGO, IL 60654Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Dietetic beverages adapted for medical purposes; Probiotic supplements; Prebiotic supplements; Probiotic preparations for medical use to help maintain a natural balance of flora in the digestive system; nutritional supplements; Health food supplements for persons with special dietary requirements; Powdered nutritional supplement drink mix; Nutritional drink mix for use as a meal replacement for medical purposes; Nutritional supplement meal replacement bars for boosting energy; nutritional supplement energy bars; preparations for supplementing the body with essential vitamins and microelements; Dietary supplements for animals; Nutritional supplements for veterinary use; Infant formula; food and beverages for babies and infants, namely, baby food; Powdered milk for babies and infants; powdered milk foods for infants; dietary supplements for infants; Medicated dental care preparations for humans and animals containing probiotic supplements; medicated animal feed; nutritionally fortified food and beverages, namely, dietetic food and beverages, for medical purposes; dietetic foods and beverages for clinical nutrition adapted for medical use; medicinal tea; medicated sweets; candy, medicated; intravenous fluids used for nutrition; medicated oral care preparations; Medicated anti-cavity mouthwashes; nutraceuticals for use as a dietary supplement; Probiotic formulas and formulations for medical purposes; biotechnological preparations for medical, pharmaceutical and veterinary purposes, namely, antibiotics; whey protein supplements; protein supplements; Vitamins, mineral supplements and mineral salt for medical purposes; herbal, food and health food supplements; bacterial preparations for medical and veterinary use; microbial preparations, probiotic bacterial formulations and supplements, for medical use; cultures of microorganisms for medical and veterinary use; Nutritional supplements for veterinary purposes; bacterial strains and cultures, all being related to probiotic bacterial formulations and supplements for medical use; bacterial cultures for medical and veterinary use; pharmaceutical and veterinary products, preparations and substances, namely, all-purpose disinfectants for use in decreasing virus and bacteria growth in aquaculture and water systems and improving water quality; immune stimulants and disinfectants for maintaining the health of aquatic animals; antibiotic preparations and products relating to the inhibition of the growth of algae, namely, biostatic antimicrobial preparations for treating algae and for inhibiting growth of those organisms; Dietetic foodstuff for animals for medical purposes; naturopathic and homeopathic preparations and substances in the nature of supplements; nutrients and nutriments in the nature of vitamin supplements; plant compounds and extracts for use as dietary supplements; Nutritional supplements, namely, carbohydrates in gel, powder and liquid form; Prebiotic products, preparations, mixtures and compositions in the nature of supplements; multi-sourced prebiotics for inclusion in animal and human health supplements; fibres, plant extracts, herbal extracts and prebiotic fibres for use as dietary supplements; medicated skin and hair care preparations, namely, creams, drops and mousse; medicinal anti-inflammatory ointments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 21, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 21, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 25, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 24, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jun 22, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 11, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 10, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Aug 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 14, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 14, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 14, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 14, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 14, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 14, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 15, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 15, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 15, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 15, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 15, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 14, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 14, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 14, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 15, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 20, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 20, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 31, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 12, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 11, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 11, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 11, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 12, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 2, 2022 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Apr 1, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 31, 2022 | NWAP | NEW APPLICATION ENTERED | — |